Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Child developmental issues news

Show

From To
Poor weight gain during first year of ART associated with increased mortality risk for children with HIV in resource-limited settings

Poor weight gain after starting antiretroviral therapy (ART) is associated with increased mortality risk for children with HIV, investigators report in the online edition of AIDS. An international team

Published
09 December 2014
By
Michael Carter
Risk of birth defects small with HIV drugs

The risks of birth defects in children exposed to antiretroviral drugs in utero are small when considering the clear benefit of preventing mother-to-child transmission of HIV but where there are safe and effective alternatives, it might be appropriate to avoid use by pregnant women of drugs that may be associated with elevated risks of birth defects, such as zidovudine and efavirenz, according to a study published by French researchers published in this week's PLOS Medicine.

Published
30 April 2014
From
EurekAlert
HIV Drug Linked to Low Bone Density in Babies

In a cohort study, babies of mothers taking tenofovir (Viread) had an average whole-body bone mineral content about 8 grams less than babies whose mothers did not use the drug, according to George Siberry, MD, of the National Institute of Child Health and Human Development in Bethesda, Md

Published
07 March 2014
From
MedPage Today
Intrauterine, postnatal growth unaffected by exposure to HIV, antenatal antiretrovirals

Exposure to HIV and antenatal antiretrovirals did not significantly affect infants’ intrauterine or early postnatal growth, according to study results published in The Pediatric Infectious Disease Journal.

Published
08 January 2014
From
Healio
Improved caregiver training helps HIV-infected children

Children born with HIV can live longer and richer lives if their caregivers receive training in ways to enhance the children’s development, according to research led by Michigan State University.

Published
15 August 2013
From
Michigan State University (press release)
Anti-HIV drugs may protect against puberty delays in HIV-infected children

For children who have been HIV-infected since birth, current anti-HIV drug regimens may protect against the delays in puberty that had been seen in HIV-infected children taking older regimens, according to researchers funded by the National Institutes of Health.

Published
15 August 2013
From
National Institutes of Health (press release)
Anti-HIV drugs in pregnancy not linked to children's language delays

The combinations of anti-HIV drugs recommended for pregnant women do not appear in general to increase their children's risk for language delay, according to a study from a National Institutes of Health research network.

Published
19 July 2013
From
National Institutes of Health (press release)
Maternal abacavir, smoking tied to heart markers in HIV-exposed kids

HIV-exposed but uninfected (HEU) children of HIV-positive mothers who took abacavir, smoked, or drank alcohol had elevated levels of cardiac biomarkers that could signal heart trouble, according to analysis of the US Pediatric HIVAIDS Cohort Study (PHACS). The study also linked cardiac biomarkers to some echocardiographic abnormalities.

Published
07 May 2013
From
International AIDS Society
Anti-HIV therapy appears to protect children's hearts, NIH network study shows

For children who have had HIV-1 infection since birth, the combination drug therapies now used to treat HIV appear to protect against the heart damage seen before combination therapies were available, according to researchers.

Published
23 April 2013
From
National Institutes of Health (press release)
HIV Drug Not Tied to Premature Births

Pregnant HIV-infected women treated with a lopinavir/ritonavir (Kaletra)-based antiretroviral regimen are at no greater risk of delivering a preterm baby than similar pregnant women given an efavirenz (Sustiva)-based treatment, researchers said here.

Published
10 March 2013
From
MedPage Today
← First123...4Next →

Filter by country